bg-img9.jpg
8.jpg
Reducing Cost within Advanced Therapy Clinical Trials

The challenge for advanced therapy companies is that they need to develop a supply chain that delivers their therapy, at scale, without adding significantly to the cost of goods sold (COGS). In this case study we’ll demonstrate how a company saw 55% cost savings across its distribution system, and increased visibility of its supply chain through meaningful data. By trusting our team of experts to deliver a robust global storage and logistics strategy, the clinical trial ran more efficiently and provided the Sponsor company with the confidence to focus on other high value activities.

Topic: Cold-Chain Logistics, Topic: Cell Therapy S..........

Conducting the Advanced Therapy Supply Chain Orchestra

A coordinated supply chain management plan is crucial when developing advanced therapies.

Topic: Cell Therapy Solutions, Content: Blog

Advanced Therapies: Reimbursement and the Impact of Hidden Supply Chain Costs

While the potential for advanced therapies to provide curative treatments to patients around the world is very exciting, the pricing strategies and reimbursement models to support this innovation are quite complicated.  In this blog, I’ll explore the cost vs. price paradigm, through a supply chain lens, highlighting hidden costs and their impact on reimbursement potential.

Topic: Cell Therapy Solutions, Content: Blog

ISCT 2017: Optimizing your Advanced Therapy Supply Chain

Ensuring that your therapy is delivered to the intended patient at the correct time and temperature are all key components for commercialization. To accomplish this, an optimized supply chain is imperative. Fisher BioServices understands these important factors and offers our global infrastructure and services to support the commercialization of advanced therapies.

Topic: Cell Therapy Solutions, Content: Blog

INSIGHTS Europe: Key Takeaways in Support of Advanced Therapies

Advanced therapies are rapidly becoming a viable therapeutic option. Thus, to ensure a patient receives an effective therapy, the supply chain will need to evolve from a clinical trial logistics paradigm to an inter-related coordinated supply chain.

Topic: Cold-Chain Logistics, Topic: Cell Therapy S..........